Benjamin Edwards’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.03M Buy
10,597
+234
+2% +$22K 0.01% 800
2026
Q2
$929K Sell
10,363
-34
-0.3% -$2.8K 0.01% 833
2026
Q1
$824K Buy
+10,397
New +$840K 0.01% 828

Other funds holding PBE

Benjamin Edwards's PBE Position: Q3 2026 in Review

Benjamin Edwards increased its Invesco Biotechnology & Genome ETF (PBE) stake by 2.3% in Q3 2026, buying an estimated $22K and bringing the position to 10,597 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #800.

Benjamin Edwards first reported a position in PBE in Q1 2026 and has held it in 3 quarters since. 106 funds tracked by Wall St. Rank hold PBE as of Q3 2026.

  • Benjamin Edwards held 10,597 shares of Invesco Biotechnology & Genome ETF worth $1.03M as of Q3 2026.
  • Benjamin Edwards bought 234 Invesco Biotechnology & Genome ETF shares in Q3 2026, an estimated $22K.
  • Invesco Biotechnology & Genome ETF made up 0.01% of Benjamin Edwards's portfolio in Q3 2026, its #800 holding.
  • Benjamin Edwards first reported a position in Invesco Biotechnology & Genome ETF in Q1 2026 and has held it in 3 quarters since.
  • 106 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q3 2026.

Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.